HDAC6 and esophageal squamous cell carcinoma: A selective HDAC6 inhibitor, ACY-1215, inhibited proliferation in ESCC, and caused G2/M phase arrest and apoptosis via miR-30d/PI3K/AKT/mTOR and ERK pathways.